Recent Updates
Recently added Catalysts
ATHE Negative Sentiment Score: 30/100

Notification of cessation of +securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Tuesday

Key Takeaway: Alterity Therapeutics Limited has announced the cessation of certain securities, specifically 1.5 million options expiring on November 29, 2026, due to the inability to satisfy their conditions. This lapse means that these options will no longer contribute to the company's capital structure. The announcement provides details about the current issued capital and indicates that the company is not offering any consideration for the cessation. The remaining options and equity securities are listed along with their corresponding details.

Market Sentiment Analysis

CONCERNS & RISKS

  • 1,500,000 options have ceased due to unsatisfied conditions.
  • The conditional rights to securities for specific options have lapsed.
  • The cessation of these options could indicate potential limitations on capital raising.

Full Press Release Details

THERAPEUTICS LIMITED
of this announcement
Details of +securities that have ceased
ASX +security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation
ATHAAG OPTION EXPIRING 29-NOV-2026 EX $0.0238 1,500,000 Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied 03/04/2023
to next page for full details of the announcement
THERAPEUTICS LIMITED
(the entity named above) provide the following information about our issued capital.
1.2 Registered Number Type Registration Number
ABN 37080699065
1.4 The announcement is
1.5 Date of this announcement
+security code and description
: OPTION EXPIRING 29-NOV-2026 EX $0.0238
Unquoted +equity securities that have ceased
of securities that have ceased
Lapse of conditional right to securities because the
conditions have not been, or have become incapable of being, satisfied
Date of cessation Is the entity paying any consideration for the cessation?
3/4/2023 No
other information the entity wishes to notify to ASX about the cessation?
the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:
Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 2,439,897,618
+equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 19,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 12,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 12,400,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07 674,694,939
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720
Note: the figures stated in the tables above are used
to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes
of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the
entity has advised ASX of a change to that class of +security in Part 2 of this form.

Frequently Asked Questions

What security lapsed for Therapeutics Limited?

The ATHAAG option expiring on 29-Nov-2026 lapsed.

Why did the ATHAAG option cease?

It ceased due to the lapse of conditional rights, unmet conditions.

What is the total number of issued ordinary shares?

The total number of ordinary fully paid shares is 2,439,897,618.

Is any consideration paid for the cessation?

No, there was no consideration paid for the cessation.

When did the ATHAAG option cease?

The ATHAAG option ceased on 3-Apr-2023.

Last updated: Apr 11, 2023